Ipca Laboratories Ltd (IPCALAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 950228, "name": "Ipca Labs", "stock_name": "Ipca Labs", "full_name": "Ipca Laboratories Ltd", "name_url": "stocks-analysis/ipca-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,527.80", "chg": -18, "chgp": "-1.16%", "dir": -1, "prev_price": "1,545.80", "mcapval": "39,185.00 Cr", "mcap": "Mid Cap", "scripcode": "524494", "symbol": "IPCALAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE571A01038", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "2.07 lacs", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-downgraded-to-hold-amid-valuation-and-technical-concerns-3898089", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3898089.png", "date": "2026-03-18 08:08:55", "description": "Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold by MarketsMOJO as of 17 March 2026. This revision reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong long-term returns and solid financials, evolving market dynamics and valuation pressures have prompted a more cautious stance." }, { "title": "Ipca Laboratories Ltd Hits New 52-Week High at Rs.1624", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs1624-3896579", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_priceRelatedfactors_3896579.png", "date": "2026-03-17 11:24:29", "description": "Ipca Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1624 today, marking a notable surge in its stock price and reflecting strong momentum within the Pharmaceuticals & Biotechnology sector." }, { "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3895715", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_technicaldot_3895715.png", "date": "2026-03-17 08:03:20", "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a slight dip in the daily price, the stock’s longer-term trend remains constructive, supported by a recent upgrade in its Mojo Grade from Hold to Buy, signalling renewed investor confidence." }, { "title": "Ipca Laboratories Ltd Falls 2.67%: 2 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-falls-267-2-key-factors-driving-the-weekly-decline-3891527", "imagepath": "", "date": "2026-03-14 16:08:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 2:</strong> Significant gap down opening at Rs.1,403.70 amid market concerns</p>\n <p><strong>Mar 4:</strong> Technical momentum shifts amid mixed market signals</p>\n <p><strong>Mar 5:</strong> Price recovery with a 1.61% gain to Rs.1,499.85</p>\n <p><strong>Mar 6:</strong> Week closes at Rs.1,490.55, down 0.62% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,531.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Ipca Laboratories Gains 4.71%: 3 Key Factors Driving the Week’s Outperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-471-3-key-factors-driving-the-weeks-outperformance-3891017", "imagepath": "", "date": "2026-03-14 12:06:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 9:</strong> Stock opens at ₹1,506.45 despite Sensex decline</p>\n <p><strong>Mar 11:</strong> Valuation shifts signal renewed price attractiveness</p>\n <p><strong>Mar 12:</strong> Technical momentum upgrade to bullish</p>\n <p><strong>Mar 13:</strong> MarketsMOJO upgrades rating to Buy on strong fundamentals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,490.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,560.80</di..." }, { "title": "MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-upgrades-ipca-laboratories-ltd-to-buy-on-strong-technical-and-financial-performance-3888184", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3888184.png", "date": "2026-03-13 08:10:04", "description": "Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, solid financial performance, and a robust quality profile despite a shift to a more expensive valuation. The mid-cap pharmaceutical company’s recent market performance and operational metrics have prompted analysts to revise their outlook positively as of 12 March 2026." }, { "title": "Ipca Laboratories Ltd Shows Strong Technical Momentum Amid Market Outperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-shows-strong-technical-momentum-amid-market-outperformance-3888112", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_technicaldot_3888112.png", "date": "2026-03-13 08:02:14", "description": "Ipca Laboratories Ltd has demonstrated a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. This development, coupled with strong price performance relative to the Sensex, underscores renewed investor confidence in the mid-cap pharmaceutical and biotechnology company." }, { "title": "Ipca Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3884296", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_valuationdot_3884296.png", "date": "2026-03-11 08:01:04", "description": "Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV) adjusting in line with peer averages and historical trends." }, { "title": "Ipca Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-hold-3877844", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3877844.png", "date": "2026-03-07 10:10:27", "description": "Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 March 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 928, "sid": "950228", "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "16-Mar-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "18-Feb-2026", "details": "Transcript of Conference Call held on 16.02.2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Feb-2026", "details": "Copy of Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25", "dt": "2025-08-05", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22", "dt": "2022-01-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 2: Significant gap down opening at Rs.1,403.70 amid market concerns

Mar 4: Technical momentum shifts amid mixed market signals

Mar 5: Price recovery with a 1.61% gain to Rs.1,499.85

Mar 6: Week closes at Rs.1,490.55, down 0.62% on the day

Read full news article

Ipca Laboratories Gains 4.71%: 3 Key Factors Driving the Week’s Outperformance

2026-03-14 12:06:01

Key Events This Week

Mar 9: Stock opens at ₹1,506.45 despite Sensex decline

Mar 11: Valuation shifts signal renewed price attractiveness

Mar 12: Technical momentum upgrade to bullish

Mar 13: MarketsMOJO upgrades rating to Buy on strong fundamentals

Week Open

Rs.1,490.55

Week Close

Rs.1,560.80Read full news article

MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Performance

2026-03-13 08:10:04

Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, solid financial performance, and a robust quality profile despite a shift to a more expensive valuation. The mid-cap pharmaceutical company’s recent market performance and operational metrics have prompted analysts to revise their outlook positively as of 12 March 2026.

Read full news article

Ipca Laboratories Ltd Shows Strong Technical Momentum Amid Market Outperformance

2026-03-13 08:02:14

Ipca Laboratories Ltd has demonstrated a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. This development, coupled with strong price performance relative to the Sensex, underscores renewed investor confidence in the mid-cap pharmaceutical and biotechnology company.

Read full news article

Ipca Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-11 08:01:04

Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV) adjusting in line with peer averages and historical trends.

Read full news article

Ipca Laboratories Ltd is Rated Hold

2026-03-07 10:10:27

Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 March 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News